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TO THE EDITOR:  The COVID-19 pandemic has impacted global health like few 
other crises in human history. According to the World Health Organization, more 
than 230 million cases have been confirmed, resulting in more than 4.7 million 
deaths worldwide.1 In the U.S. alone, over 43 million individuals have contracted 
COVID-19 with more than 700,000 deaths.1 
The far-reaching effects of the pandemic have also substantially impacted solid 
organ transplantation. Organ donation rates have been reported to be decreased 
by as much as 50-90% across a wide region of countries.2 Data from the United 
Network of Organ Sharing (UNOS) demonstrated a decline of more than 1/3 in the 
transplant rate in the early period of the pandemic, with a majority of UNOS 
regions reporting an increase in waitlist mortality.3 A specific analysis of heart 
transplantation in the US demonstrated a 75% increase in waitlist inactivation, a 
reduction of 37% in waitlist additions, and a 26% decline in deceased donor 
recovery when comparing to pre-pandemic data .4 
Beyond its impact on transplant trends, COVID-19 has been ruthless in its 
infection and spread, with many heart transplant recipients contracting the virus. 
Hospitalization rates for heart transplant recipients with COVID-19 infection have 
been reported to be as high as 80%, with a mortality approaching 30% in one 
multicenter European analysis.5 A more recent systematic review, including 39 
manuscripts and 415 patients, confirmed these findings with 77% of COVID 
positive heart transplant recipients requiring hospitalization resulting in an inpatient 
mortality of 25%.6 
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These disturbing statistics have spurred professional societies to urge vaccinations 
for not only those individuals who have received a solid organ transplant, but also 
those who are being considered for the transplant waitlist. Unique to individuals 
with end-stage heart failure, this also bears consideration for candidates being 
evaluated for durable mechanical circulatory support (MCS) or left ventricular 
assist devices (LVADs). The International Society of Heart and Lung 
Transplantation (ISHLT) and American Society of Transplantation recently issued 
a joint statement with the following recommendations: 
i. All solid organ transplant recipients should be vaccinated 
ii. All eligible household and close contacts should be 
vaccinated 
iii. Vaccination should occur prior to transplantation, with 
completion of the series 2 weeks before when possible 
The ISHLT has further recommended vaccination for all MCS recipients, 
regardless of prior COVID-19 infection status. These recommendations are based 
on the tremendous efficacy of vaccinations in preventing COVID-19 related 
morbidity and mortality. Full vaccination has been demonstrated to be 89% 
effective at preventing COVID-19 infection leading to hospitalization.7 This efficacy 
has been documented across age groups as well as with the most recent Delta 
variant.8 
Despite the above data and recommendations, vaccine hesitancy remains a 
problem, and individual providers as well as institutions are likely to have varied 
perspectives and policies in regards to vaccination. We, therefore, sought to define 
provider opinions and current institutional practices amongst transplant and LVAD 
health care workers. This was achieved with a 5-question anonymous survey, 
distributed via electronic communications, from September 17 – September 24, 
2021. A total of 121 responses were available for analysis. The majority of 
respondents (63%) were cardiologists involved in the care of heart transplant and 
LVAD patients. A sizeable proportion of respondents indicated that their program 
requires COVID-19 vaccination for patients to remain active on the transplant list 
or in order to be listed, 42.9% and 41.4% respectively. Only 23.1% reported a 
requirement for vaccination in patients awaiting LVAD implantation with even fewer 
required vaccinations for the primary caregiver to the patient (12.9% for transplant 
caregivers, 8.5% for LVAD caregivers). However, when asked for which 
populations they would be in favor of mandating COVID-19 vaccinations, there 
was overwhelming support for patients on the transplant list and those awaiting 
LVAD implantation, 90.9% and 77.7% respectively. The majority of respondents 
were also in support of a vaccine requirement for caregivers (80.2% for transplant 
caregivers and 71.7% for LVAD caregivers). Support for vaccination requirements 
in all four populations remained high when evaluating responses by role on the 
heart transplant team (Figure). 
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While there is largely agreement amongst providers that vaccinations should be 
mandated for individuals who are awaiting advanced heart failure therapies, that 
perhaps should extend to their caregivers; however, implementing such a policy 
would be challenging. The ethical concerns include complex considerations 
regarding the principles of autonomy, beneficence, and nonmaleficence, an 
endeavor fraught with concerns and considerations. While mandates may 
embrace the ethical principles of beneficence and nonmaleficence by promoting 
societal well-being, reducing virus transmission risk, and protecting health care 
workers and the sparse resource of a donated organ, it would undermine 
autonomy. Furthermore, such a requirement would undoubtedly impact other 
policy considerations in regard to both vaccinations as well as care giver behaviors 
and expectations. Beyond this, a more challenging question which arises with 
vaccination mandates may be the implications of such a change in policy to those 
patients already listed. If programs and providers proceed to de-list individuals who 
refuse to be vaccinated, how one addresses these vaccine hesitant candidates 
would potentially disrupt the fairness and equity of the evaluation and listing 
process. Finally, the possibility of having different expectations for transplant 
candidates as compared to LVAD candidates, regardless of the intended implant 
strategy for the latter, would be yet another policy and ethical conundrum.  
While there are inherent limitations to any data acquired by survey, we feel that 
these data provide a useful snapshot of perspectives among the transplant 
community. Additionally, we were unable to distinguish whether or not more than 
one respondent from the same institution answered the survey. As such, we 
cannot yet conclude that most institutions require or wish to require vaccination.  
The ethical and practical implications of vaccine mandates is certainly an area 
which requires thoughtful and meticulous discussion as well as research. 
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Differences in patient outcomes and factors such as patient satisfaction and 
patient provider trust between institutions that mandate the vaccine and those that 
do not would be key determinants in shaping policies surrounding vaccine 
requirements. Tailored surveys deployed to program leadership as policies evolve 
in this dynamic milieu, in addition to guidance from legal counsel, ethic committees 
and professional societies will be instrumental in approaching this challenge. In the 
interim, advanced heart failure providers should continue to broach the subject of 
vaccination with their patients. Too often patients and providers fail to engage in 
this exercise over concerns of the politicization and cultural perceptions of such 
conversations. While we struggle with the challenges of polices and mandates, we 
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